BACKGROUND & AIMS: This study attempts to elucidate a part of the genetic predisposition to the sporadic invasive ductal adenocarcinoma of the pancreas focusing on the genes implicated in the gene-environment interactions in carcinogenesis. METHODS: First, 227 single nucleotide polymorphisms (SNPs) of 46 genes were genotyped on 198 cases and 182 controls. The SNPs, which showed a significant association, were further genotyped on additional samples to perform a joint analysis (total 317 cases vs 1232 controls). The gene selected by joint analysis was resequenced for a high-density SNP typing and a haplotype analysis on 702 cases and 785 controls. Function of the risk and wild-type haplotypes was assessed using cells transfected with complementary DNA (cDNA). RESULTS: The joint analysis with multiple testing adjustment identified 2 SNPs on the methionine synthase reductase (MTRR) gene: rs162049 (intronic SNP), Fisher exact test, P = .0018; OR, 1.33; 95% CI: 1.11-1.60 and rs10380 (His595Tyr), Fisher exact test, P = .0063; OR, 1.45; 95% CI: 1.11-1.88. The SNPs remained significant in the recessive model after the permutation test for multiple testing (rs162049, P = .024; rs10380, P = .023) in the high-density analysis. Stable transfectants of the risk haplotype MTRR cDNA showed significantly elevated homocysteine levels in a culture medium, a lower level of the LINE-1 methylation, and a lower expression of the MTRR protein than did the transfectants with the wild-type haplotype cDNA. CONCLUSIONS: Our study suggested a common missense SNP of the MTRR gene as a novel pancreatic cancer susceptibility factor with a functional significance in folate-related metabolism and the genome-wide methylation status.
BACKGROUND & AIMS: This study attempts to elucidate a part of the genetic predisposition to the sporadic invasive ductal adenocarcinoma of the pancreas focusing on the genes implicated in the gene-environment interactions in carcinogenesis. METHODS: First, 227 single nucleotide polymorphisms (SNPs) of 46 genes were genotyped on 198 cases and 182 controls. The SNPs, which showed a significant association, were further genotyped on additional samples to perform a joint analysis (total 317 cases vs 1232 controls). The gene selected by joint analysis was resequenced for a high-density SNP typing and a haplotype analysis on 702 cases and 785 controls. Function of the risk and wild-type haplotypes was assessed using cells transfected with complementary DNA (cDNA). RESULTS: The joint analysis with multiple testing adjustment identified 2 SNPs on the methionine synthase reductase (MTRR) gene: rs162049 (intronic SNP), Fisher exact test, P = .0018; OR, 1.33; 95% CI: 1.11-1.60 and rs10380 (His595Tyr), Fisher exact test, P = .0063; OR, 1.45; 95% CI: 1.11-1.88. The SNPs remained significant in the recessive model after the permutation test for multiple testing (rs162049, P = .024; rs10380, P = .023) in the high-density analysis. Stable transfectants of the risk haplotype MTRR cDNA showed significantly elevated homocysteine levels in a culture medium, a lower level of the LINE-1 methylation, and a lower expression of the MTRR protein than did the transfectants with the wild-type haplotype cDNA. CONCLUSIONS: Our study suggested a common missense SNP of the MTRR gene as a novel pancreatic cancer susceptibility factor with a functional significance in folate-related metabolism and the genome-wide methylation status.
Authors: Pui-yee Fong; Megan D Fesinmeyer; Emily White; Federico M Farin; Sengkeo Srinouanprachanh; Zahra Afsharinejad; Margaret T Mandelson; Teresa A Brentnall; Matt J Barnett; Gary E Goodman; Melissa A Austin Journal: J Gastrointest Cancer Date: 2010-09
Authors: Lisa A Deroo; Sophia C E Bolick; Zongli Xu; David M Umbach; David Shore; Clarice R Weinberg; Dale P Sandler; Jack A Taylor Journal: Carcinogenesis Date: 2013-10-15 Impact factor: 4.944
Authors: Max Leenders; Samsiddhi Bhattacharjee; Paolo Vineis; Victoria Stevens; H Bas Bueno-de-Mesquita; Xiao-Ou Shu; Laufey Amundadottir; Myron Gross; Geoffrey S Tobias; Jean Wactawski-Wende; Alan A Arslan; Eric J Duell; Charles S Fuchs; Steven Gallinger; Patricia Hartge; Robert N Hoover; Elizabeth A Holly; Eric J Jacobs; Alison P Klein; Charles Kooperberg; Andrea LaCroix; Donghui Li; Margaret T Mandelson; Sara H Olson; Gloria Petersen; Harvey A Risch; Kai Yu; Brian M Wolpin; Wei Zheng; Ilir Agalliu; Demetrius Albanes; Marie-Christine Boutron-Ruault; Paige M Bracci; Julie E Buring; Federico Canzian; Kenneth Chang; Stephen J Chanock; Michelle Cotterchio; J Michael Gaziano; Edward L Giovanucci; Michael Goggins; Göran Hallmans; Susan E Hankinson; Judith A Hoffman-Bolton; David J Hunter; Amy Hutchinson; Kevin B Jacobs; Mazda Jenab; Kay-Tee Khaw; Peter Kraft; Vittorio Krogh; Robert C Kurtz; Robert R McWilliams; Julie B Mendelsohn; Alpa V Patel; Kari G Rabe; Elio Riboli; Anne Tjønneland; Dimitrios Trichopoulos; Jarmo Virtamo; Kala Visvanathan; Joanne W Elena; Herbert Yu; Anne Zeleniuch-Jacquotte; Rachael Z Stolzenberg-Solomon Journal: Cancer Causes Control Date: 2013-01-19 Impact factor: 2.506
Authors: Shirisha Chittiboyina; Zhongxue Chen; E Gabriela Chiorean; Lisa M Kamendulis; Barbara A Hocevar Journal: PLoS One Date: 2018-02-23 Impact factor: 3.240